Sentry Investment Management LLC cut its holdings in Express Scripts Holding (NASDAQ:ESRX) by 1.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 45,519 shares of the company’s stock after selling 792 shares during the period. Sentry Investment Management LLC’s holdings in Express Scripts were worth $3,398,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Van ECK Associates Corp boosted its holdings in Express Scripts by 5.1% in the 3rd quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock worth $32,072,000 after buying an additional 24,728 shares during the period. Victory Capital Management Inc. boosted its holdings in Express Scripts by 12.5% in the 3rd quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after buying an additional 3,940 shares during the period. Hendershot Investments Inc. bought a new position in Express Scripts in the 3rd quarter worth approximately $5,132,000. Crossmark Global Holdings Inc. bought a new position in Express Scripts in the 3rd quarter worth approximately $3,708,000. Finally, LMR Partners LLP bought a new position in Express Scripts in the 3rd quarter worth approximately $3,230,000. 87.46% of the stock is owned by institutional investors.

Express Scripts Holding (NASDAQ:ESRX) opened at $71.71 on Monday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a fifty-two week low of $55.80 and a fifty-two week high of $83.49. The company has a market cap of $40,614.61, a price-to-earnings ratio of 11.81, a price-to-earnings-growth ratio of 0.77 and a beta of 0.93.

Express Scripts announced that its board has authorized a stock buyback plan on Monday, December 18th that authorizes the company to buyback 45,000,000 outstanding shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its stock is undervalued.

Several research analysts recently commented on ESRX shares. Maxim Group raised their price objective on shares of Express Scripts from $78.00 to $87.00 and gave the stock a “buy” rating in a report on Thursday, December 14th. Deutsche Bank started coverage on shares of Express Scripts in a report on Monday, December 4th. They issued a “buy” rating and a $75.00 price objective for the company. Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Royal Bank of Canada set a $66.00 price objective on shares of Express Scripts and gave the stock a “hold” rating in a report on Wednesday, October 25th. Finally, SunTrust Banks set a $86.00 price objective on shares of Express Scripts and gave the stock a “buy” rating in a report on Thursday, December 21st. Six equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $78.23.

In other news, VP Christine Houston sold 10,104 shares of the firm’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now owns 87,400 shares in the company, valued at approximately $6,124,992. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,001 shares of company stock valued at $1,249,505. Insiders own 0.68% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://theolympiareport.com/2018/02/12/sentry-investment-management-llc-trims-stake-in-express-scripts-holding-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.